Optomap Retinal Imaging

The Optomap Retinal Imaging is a unique technology that captures more than 80% of your retina in one panoramic image while the traditional imaging methods typically only show 15% of your retina at one time.

The ultra-widefield view helps your doctor detect early signs of retinal diseases such as cancer, stroke, and cardiovascular disease, more effectively and efficiently.

Getting a retinal image is fast, painless, and comfortable. Nothing touches your eye at any time. It is suitable for the whole family. To have the exam, you simply look into the device one eye at a time (like looking through a keyhole) and you will see a flash of light to let you know the image of your retina has been taken.

Under normal circumstances, dilation drops might not be necessary, but your eye care practitioner will decide if your pupils need to be dilated depending on the health of your eyes. The image capture takes less than a half-second and they are available immediately for you to see your own retina. You see exactly what your eye care practitioner sees – even in a 3D animation.

Comparing retinal imaging technologies

Various clinical studies have shown that UWF imaging helps detect more pathology than traditional techniques alone. In a literature review of 32 clinical studies featuring optomap, 66 percent more pathology was found outside the traditional imaging field of view.

Optomap UWF images have also been shown to detect diabetic retinopathy with a perfect agreement with the gold standard.

Images can be taken in under a second, through 2mm pupils and most cataracts, making the device extremely patient-friendly, fast to operate and suitable for the majority of patients including children and the elderly.

Further reading

Nonmydriatic ultrawide field retinal imaging compared with dilated standard 7-field 35-mm photography and retinal specialist examination for evaluation of diabetic retinopathy

Comparison of nonmydriatic digital retinal imaging versus dilated ophthalmic examination for nondiabetic eye disease in persons with diabetes